Tevogen Bio, the company’s lead initiative, has completed a proof-of-concept clinical trial demonstrating the potential of ...

For the full year FY26, GitLab expects “total revenue of $946 million to $947 million, representing a growth rate of approximately 25% year-over-year.” Non-GAAP operating income is expected to be $147 ...

DA Davidson raised the firm’s price target on Axos Financial (AX) to $107.50 from $106 and keeps a Buy rating on the shares. The firm is citing ...

General Motors delivered a 34.6% return since August, outperforming the index, but now trades near fair value at $76.05. I ...

The Cigna Group (NYSE:CI) is included among the 14 Best US Stocks to Buy for Long Term. On December 2, Guggenheim lifted the ...

AI investments are widespread across retail, but using the tech doesn’t automatically translate to business impacts, per a ...

Rio Tinto Ltd (ASX: RIO) shares are rising on Thursday. Can they continue to climb? Let's see what the broker is saying about ...

In the months since that launch, Liquid has expanded LFM2 into a broader product line — adding task-and-domain-specialized ...

Nvidia isn’t just contributing chips to the effort to transform healthcare, says VP of healthcare Kimberly Powell. It’s ...

Citing an “attractive” current trading level with “2026 likely to focus on portfolio refinement over growth,” Mr. Kornack ...

Learn how breakeven analysis helps SaaS and tech teams understand when revenue covers costs, optimize pricing, and build profitable, scalable growth models.

Aterian, Inc. (Nasdaq: ATER), a consumer products company, today announced that the Company’s Board of Directors has ...